.Pharmacolibrary.Drugs.ATC.V.V03AF11 .Pharmacolibrary.Drugs.ATC.V.V03AF11| name: | ArginineAndLysine |
| ATC code: | V03AF11 | route: | intravenous |
| n-compartments | 1 |
A combination of the amino acids L-arginine and L-lysine, primarily used to enhance renal uptake of radiolabelled somatostatin analogues during peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors. Administered as an adjunct to reduce radiation-induced nephrotoxicity. Approved as a supportive medical product for this application.
No published pharmacokinetic models reporting compartmental parameters for the combined arginine and lysine formulation in the clinical context of kidney protection during PRRT in adults; typical parameters are not reported in primary literature.